Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Revenue: 2019-2023

Historic Revenue for Benitec Biopharma (BNTC) over the last 2 years, with Jun 2023 value amounting to $7,000.

  • Benitec Biopharma's Revenue was N/A to $7,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $123,000, marking a year-over-year change of. This contributed to the annual value of $75,000 for FY2023, which is 2.74% up from last year.
  • As of Q2 2023, Benitec Biopharma's Revenue stood at $7,000, which was down 87.04% from $54,000 recorded in Q1 2023.
  • In the past 5 years, Benitec Biopharma's Revenue registered a high of $77,000 during Q4 2019, and its lowest value of -$35,000 during Q2 2020.
  • For the 3-year period, Benitec Biopharma's Revenue averaged around $21,571, with its median value being $14,000 (2022).
  • In the last 5 years, Benitec Biopharma's Revenue crashed by 98.70% in 2020 and then skyrocketed by 4,700.00% in 2022.
  • Over the past 5 years, Benitec Biopharma's Revenue (Quarterly) stood at $77,000 in 2019, then slumped by 98.70% to $1,000 in 2020, then soared by 2,400.00% to $25,000 in 2021, then plummeted by 44.00% to $14,000 in 2022, then climbed by 12.50% to $7,000 in 2023.
  • Its Revenue stands at $7,000 for Q2 2023, versus $54,000 for Q1 2023 and $14,000 for Q4 2022.